Physician profile
Max L Kamerman
NPI 1568561348
$1,172.70
in general payments reported to CMS, 2019-2025
23 companies · $20.43 in 2025
The $20.43 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $90.64 · 2021: $294 · 2022: $282 · 2023: $108 · 2024: $183 · 2025: $20.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.89 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $224.24 | 2021-2024 | Adept, Seprafilm |
| Therapeuticsmd, INC. | $144.10 | 2019-2022 | |
| Exeltis, USA INC. | $128.99 | 2020-2023 | Slynd |
| Pfizer INC. | $112.85 | 2021-2022 | |
| Abbvie INC. | $62.66 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $50.52 | 2022-2023 | |
| Amag Pharmaceuticals, INC. | $45.30 | 2019 | |
| Mylan Pharmaceuticals INC. | $41.60 | 2019-2022 | |
| Evofem Biosciences, INC. | $37.19 | 2021-2022 | |
| Agile Therapeutics, INC. | $36.16 | 2021-2023 | Twirla |
| Myovant Sciences INC. | $33.75 | 2022 | |
| Organon LLC | $32.56 | 2024 | |
| Hologic Sales and Service, LLC | $30.07 | 2019 | |
| Millicent US INC | $26.70 | 2024 | |
| Covidien LP | $24.35 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $23.19 | 2019 | |
| Merck Sharp & Dohme LLC | $22.67 | 2022 | |
| Coopersurgical, INC. | $20.76 | 2023 | Summit Doppler |
| Amgen INC. | $20.66 | 2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $20.43 | 2025 | |
| Minerva Surgical, INC | $19.73 | 2022 | |
| Allergan, INC. | $14.22 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Kamerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.